At a glance
ClinicalIndex Comparison RecordN/ACompleted· 692 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE. The ROADSTER 2 Study.
In Brief
An observational study for Carotid Artery Disease. Completed, enrolled 692 participants across 43 sites in 3 countries.
Detailed Summary
The ROADSTER 2 Study is intended to evaluate real world usage of the ENROUTE Transcarotid Stent when used with the ENROUTE Transcarotid Neuroprotection System by physicians of varying experience with the transcarotid technique.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCarotid Artery Disease
CountriesGermany, Spain, United States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 2015
Enrollment StartOct 2015
Primary CompletionApr 2019
TodayJul 2026
First PostedAug 31, 2015
Enrollment StartOct 23, 2015
Primary CompletionApr 29, 2019
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 10.8 years ago